Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	1mg Delayed Start	298
Overall Study	STARTED	1mg Early Start	288
Overall Study	STARTED	2mg Delayed Start	295
Overall Study	STARTED	2mg Early Start	293
Overall Study	COMPLETED	1mg Delayed Start	231
Overall Study	COMPLETED	1mg Early Start	238
Overall Study	COMPLETED	2mg Delayed Start	241
Overall Study	COMPLETED	2mg Early Start	244
Overall Study	NOT COMPLETED	1mg Delayed Start	67
Overall Study	NOT COMPLETED	1mg Early Start	50
Overall Study	NOT COMPLETED	2mg Delayed Start	54
Overall Study	NOT COMPLETED	2mg Early Start	49

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00256204/flow